Education
About Us
Working with TipRanks
Follow Us
ScandiDos AB (SE:SDOS)
:SDOS
SDOS Stock Chart & Stats
kr1.15
kr0.01(0.67%)
At close: 4:00 PM EST
kr1.15
kr0.01(0.67%)
Day’s Range― - ―
52-Week Rangekr0.90 - kr1.69
Previous CloseN/A
Volume16.76K
Average Volume (3M)69.69K
Market Cap
kr56.55M
Enterprise Valuekr50.86M
Total Cash (Recent Filing)kr5.70M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.40
Next Earnings
Mar 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding57,011,086
10 Day Avg. Volume66,689
30 Day Avg. Volume69,692
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.28
Price to Sales (P/S)0.95
P/FCF Ratio-21.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Conservative Balance SheetA near-zero debt profile materially reduces solvency and refinancing risk, giving management flexibility to weather ongoing operating losses. Over the next 2–6 months this provides durable runway to prioritize product development, service delivery and selective investments without immediate debt servicing pressure.
High Product-level Gross MarginsA sustained ~55% gross margin implies strong unit economics and pricing power for the core QA products and software. If revenue stabilizes or grows, these margins enable operating leverage, making it feasible to improve operating profitability over time without requiring proportional revenue expansion.
Recurring Aftermarket And Software RevenueAn installed base that generates recurring service and software income provides predictable, higher-margin revenue over time. Durable aftermarket streams smooth procurement-cycle volatility at hospitals and create customer stickiness that can support margin recovery and cash generation over a multi-quarter horizon.
Bears Say
Negative And Deteriorating Free Cash FlowPersistently negative and worsening free cash flow indicates cash burn that reduces operational runway and forces reliance on external financing or equity raises. This constrains durable investments in sales, R&D and global support needed to scale the installed base and sustain long-term growth.
Persistent Operating Losses And Weak EBITFlat or slightly declining revenue combined with negative EBIT shows the company struggles to convert healthy gross margins into operating profits. Over several quarters this limits ability to self-fund growth initiatives and undermines prospects for durable margin improvement absent structural cost or revenue changes.
Volatile Historical Earnings And Execution RiskWide swings in profitability year-to-year signal execution variability and demand sensitivity in the radiotherapy market. This volatility increases forecasting risk, complicates hiring and R&D planning, and weakens confidence among hospital customers and partners over a durable 2–6 month planning horizon.
SDOS FAQ
What was ScandiDos AB’s price range in the past 12 months?
ScandiDos AB lowest stock price was kr0.90 and its highest was kr1.69 in the past 12 months.
What is ScandiDos AB’s market cap?
ScandiDos AB’s market cap is kr56.55M.
When is ScandiDos AB’s upcoming earnings report date?
ScandiDos AB’s upcoming earnings report date is Mar 18, 2026 which is in 30 days.
How were ScandiDos AB’s earnings last quarter?
ScandiDos AB released its earnings results on Dec 16, 2025. The company reported kr0.005 earnings per share for the quarter, beating the consensus estimate of N/A by kr0.005.
Is ScandiDos AB overvalued?
According to Wall Street analysts ScandiDos AB’s price is currently Overvalued.
Does ScandiDos AB pay dividends?
ScandiDos AB does not currently pay dividends.
What is ScandiDos AB’s EPS estimate?
ScandiDos AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ScandiDos AB have?
ScandiDos AB has 57,011,086 shares outstanding.
What happened to ScandiDos AB’s price movement after its last earnings report?
ScandiDos AB reported an EPS of kr0.005 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.774%.
Which hedge fund is a major shareholder of ScandiDos AB?
Currently, no hedge funds are holding shares in SE:SDOS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ScandiDos AB
ScandiDos AB (publ) provides measurement systems and software designed for the QA and validation requirements of the new treatments implemented in clinics worldwide. The company offers Delta4 Family solution for pre treatment and at treatment dose verification covering various treatment technologies, such as VMAT, IMRT, SBRT, 4D-RT, and TomoTherapy; Delta4 Discover, a transmission detector that provides confidence and patient safety based on real time measurements; and Delta4 Phantom+, a system that offers accurate and verification of IMRT, VMAT, and TomoTherapy plans. It also provides HexaMotion, a motion management solution; Delta4DVH Anatomy, a software that verifies and analyzes the dose delivered in the patient anatomy; and Delta4 Machine QA, a software to perform QA with respect to rotation, start-up behavior, and dynamic beam modulation. The company was founded in 2005 and is headquartered in Uppsala, Sweden.
Technical Analysis
Clinical Laserthermia Systems AB Class B
―
SpectraCure AB
―
C-Rad AB Class B
―
Luxbright AB
―
Mentice AB
―